 SAN DIEGO, Nov. 11, 2021 PRNewswire -- Kintara Therapeutics, Inc. Nasdaq: KTRA, a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announces today that its Chief Executive Officer, Robert E. Hoffman, will present a corporate overview at the Q4 Investor Summit Conference, which is being held virtually on November 16 17, 2021. 